Donnen P, Sylla A, Dramaix M, Sall G, Kuakuvi N, Hennart P
Department of Epidemiology and Preventive Medicine, Université Libre de Bruxelles, School of Public Health, Brussels, Belgium.
Eur J Clin Nutr. 2007 Dec;61(12):1393-9. doi: 10.1038/sj.ejcn.1602671. Epub 2007 Feb 14.
In vitamin A-deficient populations, children hospitalized with infections and/or malnutrition are at particular risk of developing severe vitamin A (VA) deficiency. High-dose VA supplements are recommended as part of the treatment but results on its effect on recovery from morbidity and on prevention from nosocomial morbidity are conflicting.
We aimed to assess the effect of a single high dose and daily low dose of VA on hospitalized malnourished children's morbidity.
We carried out a double-blind, randomized trial in 604 and 610 Senegalese hospitalized children. The first mentioned batch received a high-dose VA supplement (200,000 IU) on admission, the second a daily low-dose VA supplement (5000 IU per day) during hospitalization. Children were followed up until discharged. Data on all-cause morbidity were collected daily.
Survival analysis showed that the incidence of respiratory disease was significantly lower in the low-dose group than in the high-dose group, hazard ratios (HR): 0.26, 95% CI: 0.07-0.92. The duration of respiratory infection was also significantly lower in the low-dose group than in the high-dose group (HR of cure: 1.41, 95% CI: 1.05-1.89). Duration and incidence of diarrhoea were not significantly different between treatment groups. In children with oedema on admission, mortality was significantly lower in the low-dose group (Adjusted odds ratio: 0.21; 95% CI: 0.05-0.99).
Daily low dose of VA compared with single high dose significantly reduced duration and incidence of respiratory infection but not of diarrhoea in hospitalized children.
在维生素A缺乏人群中,因感染和/或营养不良住院的儿童尤其容易发生严重维生素A(VA)缺乏。大剂量VA补充剂被推荐作为治疗的一部分,但关于其对疾病康复及预防医院感染性疾病的效果,研究结果存在矛盾。
我们旨在评估单次大剂量和每日小剂量VA对住院营养不良儿童疾病的影响。
我们对604名和610名塞内加尔住院儿童进行了一项双盲随机试验。第一批儿童在入院时接受大剂量VA补充剂(200,000国际单位),第二批儿童在住院期间接受每日小剂量VA补充剂(每天5000国际单位)。对儿童进行随访直至出院。每天收集全因发病率数据。
生存分析显示,低剂量组呼吸道疾病的发病率显著低于高剂量组,风险比(HR):0.26,95%置信区间:0.07 - 0.92。低剂量组呼吸道感染的持续时间也显著低于高剂量组(治愈的HR:1.41,95%置信区间:1.05 - 1.89)。治疗组之间腹泻的持续时间和发病率没有显著差异。入院时有水肿的儿童中,低剂量组的死亡率显著较低(调整后的优势比:0.21;95%置信区间:0.05 - 0.99)。
与单次大剂量相比,每日小剂量VA显著降低了住院儿童呼吸道感染的持续时间和发病率,但对腹泻没有影响。